March 5, 2021
Seeking Alpha
IsoRay develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer. Read more
IsoRay develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer. Read more
CEO
Lori A. Woods
LifeBond is one of IsoRay's top competitors. LifeBond was founded in 2007, and its headquarters is in Keisarya, Haifa District. LifeBond competes in the Biotechnology field. LifeBond has 12 more employees than IsoRay.
March 5, 2021
Seeking Alpha
March 4, 2021
Global University Venturing
March 5, 2021
Markets Insider
Annual Revenue
$9.9M
IsoRay's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 242.1M. Over the last four quarters, IsoRay's revenue has decreased by 18.1%. Specifically, in Q4 2020's revenue was $2.4M; in Q3 2020, it was $2.4M; in Q2 2020, it was $2.3M; in Q1 2020, IsoRay's revenue was $2.9M.
No recent acquisitions found related to IsoRay
Since IsoRay was founded in 1998, it has participated in 1 round of funding. In total IsoRay has raised $728.8K. IsoRay's funding round was on Jul 2018 for a total of $728.8K
Since IsoRay was founded in 1998, it has participated in 1 round of funding. In total IsoRay has raised $728.8K. IsoRay's funding round was on Jul 2018 for a total of $728.8K
No recent investments found related to IsoRay